Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

Literature DB >> 24970900

Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

Parambir S Dulai¹, Corey A Siegel¹, Jean-Frederic Colombel², William J Sandborn³, Laurent Peyrin-Biroulet⁴.

Abstract

Entities: Disease

Keywords: IBD

Mesh：

Substances：

Year: 2014 PMID： 24970900 DOI： 10.1136/gutjnl-2014-307126

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

Keyword Cloud
Cited

× No keyword cloud information.

35 in total

Review 1. Biologic agents for IBD: practical insights.

Authors: Silvio Danese; Lucine Vuitton; Laurent Peyrin-Biroulet
Journal: Nat Rev Gastroenterol Hepatol Date: 2015-08-18 Impact factor: 46.802

Review 2. Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease.

Authors: Douglas L Nguyen; Sarah Flores; Kareem Sassi; Matthew L Bechtold; Emily T Nguyen; Nimisha K Parekh
Journal: Ther Adv Chronic Dis Date: 2015-05 Impact factor: 5.091

3. Combination Therapy for Inflammatory Bowel Disease.

Authors: Stephen B Hanauer
Journal: Gastroenterol Hepatol (N Y) Date: 2017-05

4. Bridging Gaps in Evidence-based Clinical Practice in Inflammatory Bowel Diseases: Observational Comparative Effectiveness Research for the Win.

Authors: Frank I Scott; Siddharth Singh
Journal: Clin Gastroenterol Hepatol Date: 2019-01-07 Impact factor: 11.382

5. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.

Authors: Abhinav Vasudevan; Ajay Raghunath; Shane Anthony; Cian Scanlon; Miles P Sparrow; Peter R Gibson; Daniel R van Langenberg
Journal: Dig Dis Sci Date: 2018-12-17 Impact factor: 3.199

6. Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Authors: Joseph Meserve; Satimai Aniwan; Jenna L Koliani-Pace; Preeti Shashi; Aaron Weiss; David Faleck; Adam Winters; Shreva Chablaney; Gursimran Kochhar; Brigid S Boland; Siddharth Singh; Robert Hirten; Eugenia Shmidt; Justin G Hartke; Prianka Chilukuri; Matthew Bohm; Sashidhar Varma Sagi; Monika Fischer; Dana Lukin; David Hudesman; Shannon Chang; Youran Gao; Keith Sultan; Arun Swaminath; Nitin Gupta; Sunanda Kane; Edward V Loftus; Bo Shen; Bruce E Sands; Jean-Frederic Colombel; Corey A Siegel; William J Sandborn; Parambir S Dulai
Journal: Clin Gastroenterol Hepatol Date: 2018-09-27 Impact factor: 11.382

7. Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.

Authors: Neeraj Narula; Farhad Peerani; Joseph Meserve; Gursimran Kochhar; Khadija Chaudrey; Justin Hartke; Prianka Chilukuri; Jenna Koliani-Pace; Adam Winters; Leah Katta; Eugenia Shmidt; Robert Hirten; David Faleck; Malav P Parikh; Diana Whitehead; Brigid S Boland; Siddharth Singh; Sashidhar Varma Sagi; Monika Fischer; Shannon Chang; Morris Barocas; Michelle Luo; Karen Lasch; Matthew Bohm; Dana Lukin; Keith Sultan; Arun Swaminath; David Hudesman; Nitin Gupta; Bo Shen; Sunanda Kane; Edward V Loftus; Corey A Siegel; Bruce E Sands; Jean-Frederic Colombel; William J Sandborn; Parambir S Dulai
Journal: Am J Gastroenterol Date: 2018-06-27 Impact factor: 10.864